Unwanaobong Nseyo, MD, MHS, discusses a retrospective analysis comparing treatment continuation outcomes with minimally invasive therapies for idiopathic overactive bladder.
Unwanaobong Nseyo, MD, MHS
Advertisement
Articles by Unwanaobong Nseyo, MD, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Matthew Galsky, MD, on how EV/pembrolizumab is redefining the MIBC treatment paradigm
2
Published BOND-003 data show durable responses with cretostimogene in NMIBC
3
Pearls & Perspectives: From Prostate Cancer Diagnosis to Patient Advocacy, with Gabe Canales
4
Cretostimogene Grenadenorepvec: Mechanism and Rationale
5